452 related articles for article (PubMed ID: 29235051)
1. Development of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncology.
Linzey JR; Marini BL; Pasternak A; Smith C; Miklja Z; Zhao L; Kumar-Sinha C; Paul A; Harris N; Robertson PL; Hoffman LM; Chinnaiyan A; Mody R; Koschmann C
J Neurooncol; 2018 Mar; 137(1):155-169. PubMed ID: 29235051
[TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors.
Marini BL; Benitez LL; Zureick AH; Salloum R; Gauthier AC; Brown J; Wu YM; Robinson DR; Kumar C; Lonigro R; Vats P; Cao X; Kasaian K; Anderson B; Mullan B; Chandler B; Linzey JR; Camelo-Piragua SI; Venneti S; McKeever PE; McFadden KA; Lieberman AP; Brown N; Shao L; Leonard MAS; Junck L; McKean E; Maher CO; Garton HJL; Muraszko KM; Hervey-Jumper S; Mulcahy-Levy JM; Green A; Hoffman LM; Dorris K; Vitanza NA; Wang J; Schwartz J; Lulla R; Smiley NP; Bornhorst M; Haas-Kogan DA; Robertson PL; Chinnaiyan AM; Mody R; Koschmann C
Transl Res; 2017 Oct; 188():27.e1-27.e14. PubMed ID: 28860053
[TBL] [Abstract][Full Text] [Related]
3. Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.
Kline CN; Joseph NM; Grenert JP; van Ziffle J; Talevich E; Onodera C; Aboian M; Cha S; Raleigh DR; Braunstein S; Torkildson J; Samuel D; Bloomer M; Campomanes AGA; Banerjee A; Butowski N; Raffel C; Tihan T; Bollen AW; Phillips JJ; Korn WM; Yeh I; Bastian BC; Gupta N; Mueller S; Perry A; Nicolaides T; Solomon DA
Neuro Oncol; 2017 May; 19(5):699-709. PubMed ID: 28453743
[TBL] [Abstract][Full Text] [Related]
4. Precision medicine in pediatric oncology.
Forrest SJ; Geoerger B; Janeway KA
Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid penetration of targeted therapeutics in pediatric brain tumor patients.
Guntner AS; Peyrl A; Mayr L; Englinger B; Berger W; Slavc I; Buchberger W; Gojo J
Acta Neuropathol Commun; 2020 Jun; 8(1):78. PubMed ID: 32493453
[TBL] [Abstract][Full Text] [Related]
6. Expanding Access to CNS-TAP: Design, Development, and Initial Use of a Complex Precision Health Specialty Web App for Neuro-Oncology.
Ravi K; Meng G; Roberts HJ; Schepers A; Franson A; Koschmann C; Marini BL; Flynn A
Stud Health Technol Inform; 2022 Jun; 290():804-808. PubMed ID: 35673129
[TBL] [Abstract][Full Text] [Related]
7. Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine.
Kim M; Kizilbash SH; Laramy JK; Gampa G; Parrish KE; Sarkaria JN; Elmquist WF
Pharm Res; 2018 Jul; 35(9):177. PubMed ID: 30003344
[TBL] [Abstract][Full Text] [Related]
8. Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center.
Ortiz MV; Kobos R; Walsh M; Slotkin EK; Roberts S; Berger MF; Hameed M; Solit D; Ladanyi M; Shukla N; Kentsis A
Pediatr Blood Cancer; 2016 Aug; 63(8):1368-74. PubMed ID: 27082517
[TBL] [Abstract][Full Text] [Related]
9. Molecular Diagnostics in Pediatric Brain Tumors: Impact on Diagnosis and Clinical Decision-Making - A Selected Case Series.
Bächli H; Ecker J; van Tilburg C; Sturm D; Selt F; Sahm F; Koelsche C; Grund K; Sutter C; Pietsch T; Witt H; Herold-Mende C; von Deimling A; Jones D; Pfister S; Witt O; Milde T
Klin Padiatr; 2018 Oct; 230(6):305-313. PubMed ID: 29996150
[TBL] [Abstract][Full Text] [Related]
10. Molecular Tumor Boards: Realizing Precision Oncology Therapy.
Patel M; Kato SM; Kurzrock R
Clin Pharmacol Ther; 2018 Feb; 103(2):206-209. PubMed ID: 29134641
[TBL] [Abstract][Full Text] [Related]
11. Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.
Gajjar A; Bowers DC; Karajannis MA; Leary S; Witt H; Gottardo NG
J Clin Oncol; 2015 Sep; 33(27):2986-98. PubMed ID: 26304884
[TBL] [Abstract][Full Text] [Related]
12. Applications of Genomic Sequencing in Pediatric CNS Tumors.
Bavle AA; Lin FY; Parsons DW
Oncology (Williston Park); 2016 May; 30(5):411-23. PubMed ID: 27188671
[TBL] [Abstract][Full Text] [Related]
13. New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting.
Doolittle ND; Abrey LE; Bleyer WA; Brem S; Davis TP; Dore-Duffy P; Drewes LR; Hall WA; Hoffman JM; Korfel A; Martuza R; Muldoon LL; Peereboom D; Peterson DR; Rabkin SD; Smith Q; Stevens GH; Neuwelt EA
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):421-8. PubMed ID: 15701824
[TBL] [Abstract][Full Text] [Related]
14. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
[TBL] [Abstract][Full Text] [Related]
15. Giving Up on Precision Oncology? Not So Fast!
Warner JL
Clin Transl Sci; 2017 May; 10(3):128-129. PubMed ID: 28146309
[No Abstract] [Full Text] [Related]
16. Precision Neuro-oncology: the Role of Genomic Testing in the Management of Adult and Pediatric Gliomas.
Ramkissoon LA; Britt N; Guevara A; Whitt E; Severson E; Sathyan P; Gay L; Elvin J; Ross JS; Brown C; Stogner-Underwood K; Mott R; Kram D; Strowd R; Lesser GJ; Ramkissoon SH
Curr Treat Options Oncol; 2018 Jun; 19(8):41. PubMed ID: 29931654
[TBL] [Abstract][Full Text] [Related]
17. Ethical considerations of neuro-oncology trial design in the era of precision medicine.
Gupta S; Smith TR; Broekman ML
J Neurooncol; 2017 Aug; 134(1):1-7. PubMed ID: 28555425
[TBL] [Abstract][Full Text] [Related]
18. Importance of dose intensity in neuro-oncology clinical trials: summary report of the Sixth Annual Meeting of the Blood-Brain Barrier Disruption Consortium.
Doolittle ND; Anderson CP; Bleyer WA; Cairncross JG; Cloughesy T; Eck SL; Guastadisegni P; Hall WA; Muldoon LL; Patel SJ; Peereboom D; Siegal T; Neuwelt EA
Neuro Oncol; 2001 Jan; 3(1):46-54. PubMed ID: 11305417
[TBL] [Abstract][Full Text] [Related]
19. Next generation neuro-oncology.
Weller M
Eur J Cancer; 2018 Jun; 96():1-5. PubMed ID: 29656021
[TBL] [Abstract][Full Text] [Related]
20. Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions.
Nadauld LD; Ford JM; Pritchard D; Brown T
Health Aff (Millwood); 2018 May; 37(5):751-756. PubMed ID: 29733728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]